Ian E. Krop, MD, PhD
Articles
Datopotamab Deruxtecan Demonstrates Manageable Safety Profile in TNBC
January 10, 2022
Video
Compared with other antibody-drug conjugates, datopotamab deruxtecan was associated with lower rates of neutropenia, pneumonitis, and hematologic toxicity.